Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.
<h4>Background</h4>Surrogate markers of protective immunity to malaria in humans are needed to rationalize malaria vaccine discovery and development. In an effort to identify such markers, and thereby provide a clue to the complex equation malaria vaccine development is facing, we invest...
Guardado en:
Autores principales: | Christian Roussilhon, Claude Oeuvray, Christine Müller-Graf, Adama Tall, Christophe Rogier, Jean-François Trape, Michael Theisen, Aissatou Balde, Jean-Louis Pérignon, Pierre Druilhe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae1745a14b3e4860b819082f466237b5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plasmodium falciparum immunodominant IgG epitopes in subclinical malaria
por: Isabel G. Azcárate, et al.
Publicado: (2020) -
Neutrophils dominate in opsonic phagocytosis of P. falciparum blood-stage merozoites and protect against febrile malaria
por: Asier Garcia-Senosiain, et al.
Publicado: (2021) -
Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination
por: Mads Delbo Larsen, et al.
Publicado: (2021) -
P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5
por: Francis Galaway, et al.
Publicado: (2017) -
PfCERLI1 is a conserved rhoptry associated protein essential for Plasmodium falciparum merozoite invasion of erythrocytes
por: Benjamin Liffner, et al.
Publicado: (2020)